Basics Sutro Biopharma, Inc. IPO Date: October 12, 2018 Sector: Healthcare Industry: Biotech Market Cap: $89.86M Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 3.41% Avg Daily Range (30 D): $0.03 | 3.78% Avg Daily Range (90 D): $0.04 | 4.17% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): .38M Avg Daily Volume (90 D): .67M Trade Size Avg Trade Size (Sh.): 115 Avg Trade Size (Sh.) (30 D): 260 Avg Trade Size (Sh.) (90 D): 229 Institutional Trades Total Inst.Trades: 641 Avg Inst. Trade: $1.62M Avg Inst. Trade (30 D): $2.14M Avg Inst. Trade (90 D): $2.14M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.63M Avg Closing Trade (30 D): $5.12M Avg Closing Trade (90 D): $5.12M Avg Closing Volume: 160.39K     News Aug 28, 2025 @ 2:44 PM FDA Tightens Survival Standards as Cancer Drug Pip... Source: Prnewswire May 1, 2025 @ 3:01 PM New Cancer Treatments Spark Hope as Traditional Fu... Source: Prnewswire Mar 15, 2025 @ 10:40 PM Sutro Biopharma Presents Data from Dose-Optimizati... Source: Sutro Biopharma, Inc. Sep 19, 2024 @ 4:08 PM Cancer Research Sees Major Boost as New Breakthrou... Source: Prnewswire Sep 11, 2024 @ 12:00 PM Sutro Biopharma to Host Research Forum Highlightin... Source: Sutro Biopharma, Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-2.52 $-.14 $-.91 Diluted EPS $-2.52 $-.14 $-.91 Revenue $ 104.47M $ 63.75M $ 17.4M Gross Profit $ $ $ Net Income / Loss $ -208.7M $ -11.5M $ -75.97M Operating Income / Loss $ -205.04M $ -3.35M $ -68.51M Cost of Revenue $ $ $ Net Cash Flow $ -26.76M $ -42.2M $ -84.08M PE Ratio